Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05389657 · ClinicalTrials.gov registry record · NA
Optimizing Provider Training in Eating Disorders (OPTED)
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 85
- Enrollment target
NCT05389657: Completed NA study, sponsored by University of California, San Francisco.
NCT05389657 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 85 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05389657, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 85 participants
- Enrollment target
Study Summary
This is a randomized controlled trial for mental health clinicians comparing two methods of training in family-based treatment (FBT) for restrictive eating disorders.
Primary Outcome
Training completion will be the number of participants who complete the full course of training.
Interventions
- BEHAVIORAL Web-based training
- BEHAVIORAL Live training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 85 participants |
| Start Date | 2022-07-14 |
| Est. Completion | 2024-06-03 |
| Phase | NA |
What the finished NCT05389657 record still lists
NCT05389657 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 85 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Web-based training is the first listed.
NCT05389657 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05389657 about?
NCT05389657 is a clinical study titled "Optimizing Provider Training in Eating Disorders (OPTED)". This is a randomized controlled trial for mental health clinicians comparing two methods of training in family-based treatment (FBT) for restrictive eating disorders.
What is the current status of trial NCT05389657?
This trial is currently completed. It is a NA study. The enrollment target is 85 participants. The study started on 2022-07-14. Estimated completion is 2024-06-03.
What interventions are being tested in trial NCT05389657?
The interventions under investigation include: Web-based training (BEHAVIORAL), Live training (BEHAVIORAL).
Who is sponsoring clinical trial NCT05389657?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05389657's enrollment target sits among peer trials
85 980th of 2000 higher than 1,018 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00842283 · 85 participants
Role of Angiogenesis in Dermatologic Diseases: A Potential Therapeutic Target
- NCT02133196 · 85 participants · Phase 2
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
- NCT03823144 · 85 participants · NA
Intravital Microscopy in Human Solid Tumors
- NCT03875638 · 85 participants · Phase 2
Treating Hyperexcitability in AD With Levetiracetam
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI